Cause of death in men diagnosed with prostate carcinoma

Cancer

Volumn 83, Issue 6, 1998, Pages 1180-1188

  Satariano, William A ^a   Ragland, Kathleen E ^a   Van Den Eeden, Stephen K ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DIVISION OF RESEARCH   (United States)

Author keywords

Age; Cause of death; Comorbidity; Prostate carcinoma; Race

Indexed keywords

ADULT; AGED; AGING; ARTICLE; CANCER PATIENT; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COMORBIDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; RACE DIFFERENCE;

AFRICAN AMERICANS; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CAUSE OF DEATH; COMORBIDITY; DEATH CERTIFICATES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GROUP PRACTICE, PREPAID; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS;

EID: 0032530122     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980915)83:6<1180::AID-CNCR18>3.0.CO;2-1     Document Type: Article

References (17)

1. Miller BA, Hayes RB, Potosky AL, Brawely O, Kaplan R. Prostate. In: Miller BA, Ries LAG, Hankey BF, Kosary CL, Harras A, Devesa SS, et al., editors. SEER Cancer Statistics Review: 1973-1990. Bethesda (MD): National Cancer Institute; 1993 NIH Pub. No. 93-2789.
2. Manton KG, Wrigley JM, Cohen HJ, Woodbury MA. Cancer mortality, aging, and patterns of comorbidity in the United States: 1968 to 1986. J Gerontol 1991;46:S225-34.
3. Guralnik JM, LaCroix AZ, Everett DF, Kovar MG. Aging in the eighties: the prevalence of comorbidity and its association with disability. Hyattsville (MD): National Center for Health Statistics; 1989 Pub. No. 170.
4. Feinstein AR, Schimpff CR, Hull EW. A reappraisal of staging and therapy for patients with cancer of the rectum: I. development of two new systems of staging. Arch Intern Med 1975;135:1441-53.
5. Feinstein AR, Schimpff CR, Andrews JF, Wells CK. Cancer of the larynx: a new staging system and a re-appraisal of prognosis and treatment. J Chron Dis 1977;30:277-305.
6. Boyd NF, Clemens JD, Feinstein AR. Pretherapeutic morbidity in the prognostic staging of acute leukemia. Arch Intern Med 1979;139:324-8.
7. Wells CK, Stoller JK, Feinstein AR, Horowitz RI. Comorbid and clinical determinants of prognosis in endometrial cancer. Arch Intern Med 1984;144:2004-9.
8. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987;40:373-83.
9. Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 1994;120:104-10.
10. Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J. The impact of co-morbidity on life expectancy among men with localized prostate cancer. J Urol 1996;156:127-32.
11. Fowler JE, Terrell FL, Renfroe DL, Co-morbidities and survival of men with localized prostate cancer treated with surgery or radiation therapy. J Urol 1996;156:1714-8.
12. Concato J, Horwitz RI, Feinstein AR, Elmore JG, Schiff SF. Problems of comorbidity in mortality after prostatectomy. JAMA 1992;267:1077-82.
13. Arellano MG, Petersen GR, Petitti DB, Smith RE. The California Automated Mortality Linkage System (CAMLIS). Am J Public Health 1984;74:1324-30.
14. Havlik RJ, Rosenberg HM. The quality and application of death records of older persons. In: Wallace RB, Woolson RF, editors. The epidemiologic study of the elderly. New York: Oxford University Press, 1992:262-80.
15. Fleiss JL. Statistical methods for rates and proportions. 2nd edition. New York: John Wiley & Sons, 1981:212-36.
16. Guralnik JM. Assessing the impact of comorbidity in the older population. Ann Epidemiol 1996;6:376-80.
17. West DW, Satariano WA, Ragland, DR, Hiatt RA. Comorbidity and breast cancer survival: a comparison between black and white women. Ann Epidemiol 1996;6:413-9.